Brendan Harley

Researchers at the University of Illinois Urbana-Champaign have recently received a three-year commitment of $250,000 for examining Ehlers-Danlos syndrome. The labs of Christina Laukaitis (RBTE/EIRH), a clinical associate professor at the Carle Illinois College of Medicine, and Brendan Harley (RBTE/EIRH), a Robert W. Schaefer Professor of chemical and biomolecular engineering, will use the donation to support research efforts and plan for workshops.

Glioblastoma is the most common type of brain tumor that affects adults and, unfortunately, still remains incurable. In a new study, researchers have demonstrated that a specific mitochondrial protein plays an important role in glioblastoma, and can therefore be used as a potential target to reduce tumors.

The bones of the face and skull can be affected due to a wide range of conditions, including cleft palate defects, traumatic injuries, cancer, and bone loss from dentures. Although bone replacements are routinely used to regenerate the missing tissue, they are vulnerable to bacterial infection. In a new study, researchers investigated whether manuka honey, made from tea trees, can be used to resist bacterial infection and promote bone growth.

Science storytelling organization The Story Collider develops “true, personal stories about science” as part of their mission to reveal the vibrant role that science plays in all of our lives through the power of storytelling. Two IGB members will be featured on the November 25th episode of the Story Collider weekly podcast, which will be titled “Unlikely Paths: Stories from the Carl R. Woese Institute for Genomic Biology.”

In light of long-standing inequities in STEM representation, many universities are now recognizing the value of diversity in higher education. Achieving such diversity involves creating an inclusive campus that welcomes scholars from different backgrounds, not only to foster a healthy intellectual environment, but also to provide role models to aspiring students. Faculty cluster hiring is an emerging practice in higher education, involving cross-campus collaborations to hire faculty working on interdisciplinary research topics.

Brendan A. C. Harley (RBTE/EIRH)—a leader in the fields of biomaterials, tissue engineering, and regenerative medicine—has been named the Robert W. Schaefer

Bone injuries in the face and skull—known as craniomaxillofacial defects—can be caused by sports injuries, vehicle accidents, or battlefield injuries. Repairing such defects is complicated because different types of cells need to interact with each other. In a new study, researchers are investigating the types of material used in reconstruction to see which one works best.

A new research project led by the University of Illinois Urbana-Champaign aims to develop biomaterials that are strong, malleable, and support stem cell growth to transform skull reconstruction surgeries with a $2.4 million grant over five years from the National Institute of Dental and Craniofacial Research, a branch of the U.S. National Institutes of Health. 

Several Cancer Center at Illinois (CCIL) and IGB members are joining forces with scientists from the Mayo Clinic and Georgetown University on an expansive project targeting improved treatment for glioblastoma (GBM), the most aggressive form of brain cancer. The team, led by Brendan Harley (RBTE leader/EIRH), professor of chemical and biomolecular engineering, recently received a $3M grant from the National Cancer Institute (NCI) for their research which will unite the cell biology, bioengineering, and chemistry behind cancer drug development.

Neurological diseases such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis affect millions of people worldwide and yet, there exist no known cures. Multiple sclerosis, a disease that causes deterioration of the nerves due to miscommunication between the brain and body, was of particular interest to Illinois alumnus Scott Fisher. As an alumnus, Fisher had a desire to give back to the university but to also honor his late wife Bonita J. Fisher, who was diagnosed with multiple sclerosis.